Skip to main content

MJFF Publications

6341 - 6350 of 7616 Results
Title
Year
  • Year
  • 2015
  • 2015
  • 2015
  • 2015
  • 2015
  • 2015
  • 2015
  • 2015
  • 2015
  • 2015
  • RESTRICTED
    Title: The D3 dopamine receptor: From structural interactions to function
    Journal Name: European Neuropsychopharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.euroneuro.2014.11.021
    Best OA location URL:
    Citation Count: 37
  • RESTRICTED
    Title: tranSMART Foundation Datathon 1.0: The cross neurodegenerative diseases challenge
    Journal Name: Applied & Translational Genomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.atg.2015.08.004
    Citation Count: 7
  • RESTRICTED
    Title: Genome-wide variant by serum urate interaction in Parkinson's disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24504
    Best OA location URL:
    Citation Count: 8
  • RESTRICTED
    Title: Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug Screening
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0136930
    Citation Count: 19
  • RESTRICTED
    Title: Transcriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson’s disease
    Journal Name: Experimental & Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/emm.2015.54
    Citation Count: 27
  • RESTRICTED
    Title: Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-015-0038-3
    Citation Count: 91
  • RESTRICTED
    Title: Citalopram for the Treatment of Agitation in Alzheimer Dementia
    Journal Name: Journal of Geriatric Psychiatry and Neurology
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1177/0891988715601735
    Citation Count: 8
  • RESTRICTED
    Title: GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26359
    Citation Count: 157
  • RESTRICTED
    Title: Reaction-Based “Off–On” Fluorescent Probe Enabling Detection of Endogenous Labile Fe2+ and Imaging of Zn2+-induced Fe2+ Flux in Living Cells and Elevated Fe2+ in Ischemic Stroke
    Journal Name: Bioconjugate Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.5b00259
    Best OA location URL:
    Citation Count: 60
  • RESTRICTED
    Title: Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-015-0403-4
    Citation Count: 38
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.